Immunostimulatory method
US11351114B2 · kind B2 · utility
3Cited by
3References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2019 |
| Grant date | Jun 7, 2022 |
| Priority date | — |
| Expiry date | Jul 26, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.